Linden Pharma Limited - Board Members
Founded in June 2026 and headquartered in Telangana, India.
2026 Secunderabad, Telangana (India) Active
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Abdulla Abdul Aziz Ansari Appointed as Director since June 2026 | Director | 17-Jun-2026 | Current |
Aqueeluddin Ahmed Syed Appointed as Director since June 2026 | Director | 17-Jun-2026 | Current |
Areeb Abdulla Ansari Appointed as Director since June 2026 | Director | 17-Jun-2026 | Current |
Mohd Sajeed Iqubal Ansari Mohd Naseeruddin Ansari Appointed as Individual Subscriber since June 2026 | Individual Subscriber | 17-Jun-2026 | Current |
Salim Ahmad Abdul Aziz Ansari Appointed as Individual Subscriber since June 2026 | Individual Subscriber | 17-Jun-2026 | Current |
Shaik Abdul Hameed Appointed as Individual Subscriber since June 2026 | Individual Subscriber | 17-Jun-2026 | Current |
Zaid Salim Ansari Appointed as Individual Subscriber since June 2026 | Individual Subscriber | 17-Jun-2026 | Current |
Premium access Complete director detailsUnlock the complete director and KMP records available for Linden Pharma Limited.
Verified entity values are shown only after access is granted. | |||
People Timeline
Explore the timeline of key personnel in Linden Pharma Limited's leadership journey.
Loading...
Frequently Asked Questions
You can contact Linden Pharma Limited through their registered address at 42-792/1/1/1 Maruthi, Nagar, Satyagi Ri Colony, Secunderabad Telangana, 500040, India, or via their website if available. Social media links are also provided where applicable.
The current directors of Linden Pharma Limited are listed above in the "Current Directors & Signatories" section. You can view their names, designations, and appointment dates.
- Shaik Abdul Hameed
- Salim Ahmad Abdul Aziz Ansari
- Mohd Sajeed Iqubal Ansari Mohd Naseeruddin Ansari
- Areeb Abdulla Ansari
- Abdulla Abdul Aziz Ansari
- Aqueeluddin Ahmed Syed
Past director details are available under the "Past Directors & Signatories" tab. You may need to upgrade your subscription to view detailed information.